| Change in body weight | Over six months, body weight fell by an average of 1.8 kg with berberine and 1.9 kg with placebo. The trial found no additional weight loss with berberine. The adjusted difference was +0.05 kg, with a 95% confidence interval from −0.74 to +0.84 kg. | 2/4 LowConfidence is low because this was an additional outcome in one trial in a specific population. The range of the estimate allows for a small difference in either direction. This result does not mean that body weight stayed the same. | 1randomized trialBerberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗ | The trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial. | - Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
|
|---|
| Fat around the internal organs | The area of fat around the internal organs, measured by CT, fell by an average of 0.6% with berberine and 2.0% with placebo. The trial found no advantage for berberine. The adjusted difference in change was +1.38 percentage points, with a 97.5% confidence interval from −2.43 to +5.18. | 3/4 ModerateConfidence is moderate because this was a primary outcome in a randomized trial with 337 participants. The analysis accounted for missing measurements statistically. A small difference between the groups is still possible. | 1randomized trialBerberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗ | The trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial. | - Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
|
|---|
| Fasting blood sugar | Over 16 weeks, average fasting blood sugar went from 6.49 to 6.20 mmol/L with berberine and from 6.43 to 6.67 mmol/L in the control group. The adjusted reduction relative to control was 0.50 mmol/L, with a 95% confidence interval from 0.15 to 0.85 mmol/L. | 2/4 LowConfidence is low because the evidence comes from one trial. The analysis included only participants with at least one follow-up measurement and filled in missing values with the last known value. The finding applies to people with elevated blood sugar. People with normal blood sugar are outside its scope. | 1randomized trialEffectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗ | Adults aged 18–70 with newly identified elevated blood sugar. A total of 150 people were assigned to the two groups relevant to this comparison. The analysis included 49 in the berberine group and 99 in the control group. | - Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study ↗
|
|---|
| LDL cholesterol | Over six months, LDL cholesterol, often called “bad” cholesterol, fell by 7.72 mg/dL more with berberine than with placebo. The 95% confidence interval for the additional reduction was 1.93 to 13.13 mg/dL. This comparison did not assess how often heart attacks occurred. | 2/4 LowConfidence is low because LDL cholesterol was an additional outcome in one trial. Researchers assessed many outcomes without adjusting for multiple comparisons. The finding concerns a blood test and does not establish that any cardiac events were prevented. | 1randomized trialBerberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗ | The trial included 337 adults with obesity and fatty liver disease who did not have diabetes. Of these, 169 received berberine and 168 received placebo. Everyone took berberine for 30 days before group assignment. People who could not tolerate it were excluded from the main trial. | - Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial ↗
|
|---|
| Diarrhea frequency in IBS | Over eight weeks, average diarrhea frequency recorded in diaries fell by about 70% with berberine and 15% in the control group. These relative changes within each group were calculated from the table in the article. The advantage for berberine at week eight was statistically significant. Four weeks after treatment stopped, there was no longer a difference between the groups. | 1/4 Very lowConfidence is very low because the evidence comes from one small trial and 32 of the 164 participants were missing from the final results. Participants recorded symptom frequency themselves, and complete results are unavailable for those who dropped out. | 1randomized trialA Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗ | Adults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks. | - A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗
|
|---|
| Abdominal pain frequency in IBS | Over eight weeks, abdominal pain frequency recorded in diaries fell by 64.6% with berberine and 29.4% in the control group. These percentages measure the decline from baseline in each group and do not indicate how many people benefited. At week eight, the difference between the groups was statistically significant. | 1/4 Very lowConfidence is very low because the findings come from one trial with substantial dropout. Researchers assessed several symptoms repeatedly. This finding concerns pain frequency in people with IBS with diarrhea. | 1randomized trialA Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗ | Adults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks. | - A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗
|
|---|
| Quality of life in IBS | Over eight weeks, the average score on an IBS quality-of-life questionnaire rose from 122.20 to 158.47 points with berberine and from 126.63 to 131.57 points in the control group. Higher scores indicate better quality of life. The changes were +36.27 and +4.94 points, respectively. The difference between the groups at the end of treatment was statistically significant. | 1/4 Very lowConfidence is very low because this was an additional questionnaire in one trial with participant dropout. The questionnaire assessed quality of life in people with IBS. It did not assess mood in healthy people. | 1randomized trialA Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗ | Adults with irritable bowel syndrome with diarrhea. The trial assigned 164 people, 82 to each group. Of these, 70 in the berberine group and 62 in the control group completed eight weeks. | - A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome ↗
|
|---|
| Perceived exertion while running in the heat | In eight young adults doing the same one-hour run in the heat, average perceived exertion was 1.7 points lower with berberine, at 11.4 points versus 13.1 points with placebo. Participants ran at 35 °C at an intensity of about 60% of their individual maximal oxygen uptake. The trial did not assess athletic performance or protection against overheating. | 2/4 LowConfidence is low because the study included only eight participants and treatment was brief. The study measured several responses to the same workload. It did not assess improvements in speed or endurance. | 1randomized trialDietary berberine supplementation improves select physiological and psychological responses during exertional heat stress: A pilot study in young adults ↗ | Eight young adults, six men and two women. Each completed both periods in random order. | - Dietary berberine supplementation improves select physiological and psychological responses during exertional heat stress: A pilot study in young adults ↗
|
|---|